[go: up one dir, main page]

CO5241360A1 - Composiciones de flint y usos de estas - Google Patents

Composiciones de flint y usos de estas

Info

Publication number
CO5241360A1
CO5241360A1 CO99076841A CO99076841A CO5241360A1 CO 5241360 A1 CO5241360 A1 CO 5241360A1 CO 99076841 A CO99076841 A CO 99076841A CO 99076841 A CO99076841 A CO 99076841A CO 5241360 A1 CO5241360 A1 CO 5241360A1
Authority
CO
Colombia
Prior art keywords
replaced
val
gly
leu
ile
Prior art date
Application number
CO99076841A
Other languages
English (en)
Inventor
Yeong Song Ho
Paul Robert Rostek
Su Eric Wen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO5241360A1 publication Critical patent/CO5241360A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • G01N2333/4704Inhibitors; Supressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un ácido nucleico aislado que codifica una proteína que tiene la secuencia SEC Nº ID 4. ácido nucleico aislado que codifica una proteína FLINT que tiene al menos una sustitución en la SEC Nº ID 2 seleccionada entre el grupo formado por: a) La Ser en posición 10 se sustituye de forma alternativa por Thr, Leu, Val, Ile, Gly o Ala, b) La Leu en posición 16 se sustituye de forma alternativa por Ile, Val, Ala o Gly, c) La Pro en posición 23 se sustituye de forma alternativa por Leu, lle, Val, Ala, o Gly, d) La Val en posición 27 se sustituye de forma alternativa por Gly, Ala Leu o Ile, f) La Val en posición 30 se sustituye de forma alternativa por Leu, Ile, Val, Ala o Gly, f) La Ala en posición 31 se sustituye de forma alternativa por Gly, Val, Leu o Ile,g) La Thr en posición 33 se sustituye de forma alternativa por ser, Ala, Gly, Leu, Val o lle, h) La Ala en posición 41 se sustituye de forma alternativa por Thr, Gly, Val, Leu o Ile, i) El Glu en posición 42 se sustituye de forma alternativa por Asn o Gln,j) La Arg en posición 46 se sustituye de forma alternativa por His o Lys, k) La Arg en posición 60 se sustituye de forma alternativa por His o Lys,l) La Ala en posición 104 se sustituye de forma alternativa por Gly, Val, Leu o Ile, m) La Ser en posición 131 se sustituye de forma alternativa por Thr, Ile, Leu, Ala o Gly, n) La Ala en posición 136 se sustituye de forma alternativa por Gly, Val, Leu o Ile, o) La Ile en posición 139 se sustituye de forma alternativa por Leu, Gly, Ala o Val, p) La Thr en posición 191 se sustituye de forma alternativa por Ser, Ala, Gly, Leu, Ile o Val,q) La Gly en posición 198 se sustituye de forma alternativa por Ala, Val, Ile o Leu, r) La Ala en posición 208 se sustituye de forma alternativa por Gly, Leu, Val o Ile, El Glu en posición 212 se sustituye de forma alternativa por Asp, Asn o Gln, t) La Ala en posición 238 se sustituye de forma alternativa por Gly, Leu, Val o Ile, ...
CO99076841A 1998-12-09 1999-12-07 Composiciones de flint y usos de estas CO5241360A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11157598P 1998-12-09 1998-12-09
US11158098P 1998-12-09 1998-12-09
US11506999P 1999-01-07 1999-01-07

Publications (1)

Publication Number Publication Date
CO5241360A1 true CO5241360A1 (es) 2003-01-31

Family

ID=27381019

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99076841A CO5241360A1 (es) 1998-12-09 1999-12-07 Composiciones de flint y usos de estas

Country Status (5)

Country Link
EP (1) EP1020521A1 (es)
AU (1) AU2164400A (es)
CO (1) CO5241360A1 (es)
PE (1) PE20001388A1 (es)
WO (1) WO2000034782A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
CN1247567A (zh) 1997-01-14 2000-03-15 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
WO2000058465A2 (en) * 1999-03-30 2000-10-05 Eli Lilly And Company Flint polypeptide analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712115A (en) * 1996-03-19 1998-01-27 Incyte Pharmaceuticals, Inc. Human cell death-associated protein
CN1247567A (zh) * 1997-01-14 2000-03-15 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
AU9013998A (en) * 1997-07-21 1999-02-10 Zymogenetics Inc. Tumor necrosis factor receptor ztnfr-5

Also Published As

Publication number Publication date
EP1020521A1 (en) 2000-07-19
PE20001388A1 (es) 2000-12-15
WO2000034782A1 (en) 2000-06-15
AU2164400A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
KR900017607A (ko) 프로테이나아제 억제제, 이것의 제조방법 및 이들을 함유한 의약품
HUP0001538A2 (hu) GnRH-leukotoxin kimérák
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
AR059907A2 (es) Proteina de fusion ob, secuencia de acido nucleico que codifica dicha proteina, vector que contiene dicha secuencia, proceso para producir dicha proteina, composicion farmaceutica que contiene dicha proteina y uso de dicha proteina para fabricar un medicamento
EP1092774A3 (en) Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof
MX9606536A (es) Proteinas n-terminalmente extendidas expresadas en levaduras.
ATE130869T1 (de) Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.
NO940736L (no) DNA sekvenser som koder for gelonin polypeptid
IL98024A0 (en) Cd44-surface proteins,dna-sequences coding therefor,polypeptides coded by said dna sequences and diagnostic compositions containing the same
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
CO5241360A1 (es) Composiciones de flint y usos de estas
DE69318716D1 (de) Anti-Katze Immundefiziensvirus (FIV) Impfstoffe
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
Yajima et al. A 11.5-kb 5′-terminal cDNA sequence of chicken breast muscle connectin/titin reveals its Z line binding region
DE69840326D1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
KR860006484A (ko) 단백질 또는 당단백질의 제조방법
AU5315790A (en) Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p. falciparum at the sporozoite stage and in the hepatocytes
AR012744A1 (es) Molecula de acido nucleico que codifica una proteina vinculadora de sucrosa, proteina vinculadora de sucrosa y metodo para producir una proteinavinculadora de sucrosa.
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
DE68914397D1 (de) Menschliches Lymphotoxin.
CO5210980A1 (es) PROTEINA V[sub E] Y SECUENCIAS DE ACIDO NUCLEICO, COMPOSICIONES, Y METODOS DE RESISTENCIA A PATOGENOS VEGETALES
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
AU1993201A (en) Nucleic acid sequences of hyperplasia and tumours of the thyroid

Legal Events

Date Code Title Description
FA Application withdrawn